Posted by: Salvatore J. Zambri, founding partner
Bloomberg News (BN) recently reported that, according to the Mayo Clinic, “Most scientists who published articles supporting GlaxoSmithKline Plc’s diabetes drug Avandia [rosiglitazone] after it was linked to heart disease in 2007 had financial ties to the company.”
The United Kingdom’s Independent reported, “Researchers from the Mayo Clinic in Minnesota — one of the few US research organizations that does not rely on commercial sponsorship — analyzed more than 200 articles published in scientific journals, including original papers, editorials, and letters, which commented on the heart attack risk associated with Avandia after 2007. ” The investigators “found almost half (47 percent) of the study authors had financial conflicts of interest, but almost a quarter (23 percent) did not disclose it. They were discovered by searching other publications by the same author or on the Internet.”
In February, internal documents and findings from the Food and Drug Administration, released by US Senators, made the recommendation that Avandia should be removed from the American market. The agency now plans to conduct a July meeting to weigh the pros and cons of the drug.
I blogged about the Avandia drug earlier this year. To read that blog and learn more about the risks of Avandia, please click here.
If prescribed Avandia, please contact your doctor immediately. Your doctor should not prescribe any medication without first warning you of all known risks, and only if the benefits of the medication outweigh the risks.
About the author:
Mr. Zambri is a Past-President of the Trial Lawyers Association of Metropolitan Washington, D.C. He has been acknowledged by Washingtonian magazine as a “Big Gun” and among the “top 1%” of all of the more than 80,000 lawyers in the Washington metropolitan area. The magazine also acknowledges him as “one of Washington’s best–most honest and effective lawyers” who specializes in medical malpractice matters, product liability claims, and serious automobile accident claims. Mr. Zambri has also been repeatedly named a “Super Lawyer” by Law and Politics magazine–a national publication that honors the top lawyers in America.
Mr. Zambri is regularly asked to present seminars to lawyers and doctors, as well as both medical and law students concerning medication errors, medical malpractice litigation, and safety improvements.
Mr. Zambri was sought after to publish a chapter regarding product liability litigation in Aspatore Books – a company that is touted as “the largest and most exclusive publisher of C-1 Level executives (CEO, CFO, CTO, CMO, Partner) from the world’s most respected companies and law firms.” To read Mr. Zambri’s publication, entitled “Constantly Preparing To Win”, please click here.